Suman Kambhampati
Suman Kambhampati publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments and Chronic Lymphocytic Leukemia Research.
- World rank
- #482,840 of 7,710,434 ranked researchers
- Rank in United States
- #168,699 of 1,627,098
- Works
- 195
- Citations
- 5.6k
- Citations per work
- 28.7
What does Suman Kambhampati research?
Suman Kambhampati's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9749.9%
- Medicine9749.9%
- Life Sciences5025.4%
- Everything else4824.7%
- 1Hematology24% of their works
- 2Molecular Biology20% of their works
- 3Genetics12% of their works
- 4Oncology11% of their works
- 5Immunology6% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Protein Degradation and Inhibitors
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Histone Deacetylase Inhibitors Research
- Cancer Treatment and Pharmacology
Which keywords describe Suman Kambhampati's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Diagnosis Criteria, International Myeloma Working Group, Chronic Lymphocytic Leukemia, Genomic Aberrations and BET Bromodomains.
- Histone Deacetylases
- Chemotherapy-Induced Peripheral Neuropathy
- JAK2 Mutation
- BCR-ABL
- BET Bromodomains
- Chronic Lymphocytic Leukemia
- Diagnosis Criteria
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- International Myeloma Working Group
- Genomic Aberrations
- PROTACs
- Imatinib
- Myelofibrosis
- HDAC Inhibitors
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Prognostic Factors862 topics
- AML501 topic
- Acute Myeloid Leukemia501 topic
- Diagnosis Criteria371 topic
- International Myeloma Working Group371 topic
- Chronic Lymphocytic Leukemia361 topic
- Genomic Aberrations361 topic
- BET Bromodomains221 topic
- PROTACs221 topic
- BCR-ABL211 topic
- Imatinib211 topic
- JAK2 Mutation191 topic
- Myelofibrosis191 topic
- Chemotherapy-Induced Peripheral Neuropathy121 topic
- HDAC Inhibitors121 topic
- Histone Deacetylases121 topic
- Taxanes121 topic
Where does Suman Kambhampati work?
Suman Kambhampati's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Suman Kambhampati have?
OpenAlex counts 195 works and 5,596 citations for Suman Kambhampati, an h-index of 46, ranking #482,840 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suman Kambhampati. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.